The Association between the Prevalence of Transfusion Transmitted Infections and Characteristics of Infected Blood Donors in Kerman, Iran

Document Type: Original Article

Authors

1 Nephrologist, Assistant Professor, Clinical Research Unit, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran

2 Ph.D. Candidate in Epidemiology, Physiology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

3 Clinical Research Unit, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran

Abstract

Background:Nowadays, one of the main challenges of the blood transfusion organization is the procurement, distribution, and monitoring of the appropriate use of blood and its products. Therefore, the aim of this study was to investigate the prevalence of Transfusion Transmitted Infections (TTIs) including human immunodeficiency virus (HIV+), hepatitis B virus (HBV+), and hepatitis C virus (HCV+), and also to determine the relationship between the prevalence of Transfusion Transmitted Infections and characteristics of Infected blood donors, which can be useful in the selection of blood donors.
Methods: This retrospective study was conducted on all blood donors in Kerman Province during five years (from March 2014 to February 2019). Individuals whose initial test and supplementary test results were positive, were considered as definitely positive. Chi-square test was used to investigate the relationship between measured factor and outcome. Data were analyzed by SPSS version 20. Statistically significant value was considered at P≤0.05.
Results: After confirmatory tests, it was revealed that 500 cases were infected with one of the three blood-borne viruses of HIV+, HBs+, and HCV+. Considering a 95% confidence interval, the prevalence of HIV+, HBs+, and HCV+ was, 0.0006%, 0.1%, and 0.04%, respectively. There was a significant relationship between the prevalence of infections and age, educational status (P=0.008), and donation status (P=0.007), but there was no significant relationship between the prevalence of infections and gender and marital status (P>0.05).
Conclusion: The overall prevalence of TTIs among blood donors of Kerman province was 0.14%, indicating that the prevalence of TTIs is very low, it can be due to the appropriate screening of blood donors prior to the blood donation and performing advanced screening approved by the World Health Organization. According to the results, the healthiest blood donors are regular blood donors and those with a history of blood donation.

Keywords


  1. Zolfaghari Anaraki S A tlas of Blood Transfusion [Internet]. 2011. Available from: ghhospital.mui.ac.ir/sites/ghhospital.mui.ac.ir/files/7_1_0.pdf.
  2. Salawu L, Bolarinwa R, Adegunloye A, Muraina H. HBsAg, anti-HCV, anti-HIV and VDRL in blood donors: Prevalence and trends in the last three and a half years in a tertiary health care facility in Ile-Ife, Nigeria. International Journal of Medicine and Medical Sciences. 2010;2(11):335-41.
  3. Kamran M, Mahmood RT, Khan MA, Mehmood A, Nisar L, Asad MJ. Prevalence of transfusion transmitted infections among blood donors; A prospective study. AJPCT. 2014;2(4):540-43.
  4. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfusion medicine reviews. 2012;26(2):164-80.
  5. Organization WH. Blood donor selection: guidelines on assessing donor suitability for blood donation: World Health Organization; 2012.
  6. Elbjeirami W, Arsheed N, Al-Jedani H, Elnagdi N, Eisha H, Abdulwahab A. Prevalence and trends of common transfusion transmitted infections using serological and nucleic acid markers in Saudi Blood Donors. J Blood Disord Transfus. 2015;6(3):1000280.
  7. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, et al. Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion. 2009;49(6):1115-25.
  8. Seyed-Askari SM, Beigzadeh A. The prevalence of transfusion transmitted infections among blood donors in Kerman, Iran. Journal of Kerman University of Medical Sciences. 2015.
  9. Dwyre D, Fernando La, Holland P. Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century. Vox sanguinis. 2011;100(1):92-8.
  10. Choudhary RK, Singh P, Singh H, Singh H. Algorithm to use hepatitis core antibody and/or ID-NAT for HBV screening. Zenith Int J Multidiscip Res. 2013;3(5):192-200.
  11. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors. Transfusion. 2005;45(2):254-64.
  12. Makroo RN, Hegde V, Chowdhry M, Bhatia A, Rosamma N. Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India. The Indian journal of medical research. 2015;142(3):317.
  13. Kitchen A, Barbara J. Transfusion-transmitted infections. Practical transfusion medicine. 2001:221-4.
  14. Tapko J, Sam O, Diarra-Nama A. Status of blood safety in the WHO African Region: report of the 2004 survey. Brazzaville: WHO Regional Office for Africa. 2007:1-25.
  15. Sorouri Zanjani R, Mazloomzadeh S, Koocheki A, Noori M. Prevalence of Hepatitis B, C and HIV Infection in Blood Donors in Zanjan, 2005-2006. Preventive Care In Nursing & Midwifery Journal. 2013;3(1):56-63.
  16. Ataro Z, Urgessa F, Wasihun T. Prevalence and Trends of Major Transfusion Transmissible Infections among Blood Donors in Dire Dawa Blood bank, Eastern Ethiopia: Retrospective Study. Ethiopian journal of health sciences. 2018;28(6):701-10.
  17. Bani Aghil SS, Abbasi S, Arab M, Seyedein MS. The Prevalence of HCV, HBV, HIV in Blood Donors of Golestan Province, (2006-2008). Medical Laboratory Journal. 2009;3(2):0-.
  18. Alaidarous M, Choudhary RK, Waly MI, Mir S, Bin Dukhyil A, Banawas SS, et al. The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia. Journal of infection and public health. 2018;11(5):702-6.
  19. Pillonel J, Le Marrec N, Girault A, David D, Laperche S. [Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2005;12(3):239-46.
  20. Siraj N, Achila OO, Issac J, Menghisteab E, Hailemariam M, Hagos S, et al. Seroprevalence of transfusion-transmissible infections among blood donors at National Blood Transfusion Service, Eritrea: a seven-year retrospective study. BMC Infectious Diseases. 2018;18(1):264.
  21. Arshad A, Borhany M, Anwar N, Naseer I, Ansari R, Boota S, et al. Prevalence of transfusion transmissible infections in blood donors of Pakistan. BMC hematology. 2016;16:27-.
  22. Busch M, Young M, Samson S, Mosley J, Ward J, Perkins H, et al. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening. Transfusion. 1991;31(1):4-11.